Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?

NATerminatedINTERVENTIONAL
Enrollment

295

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
HIV InfectionsHelminthiasis
Interventions
DRUG

Praziquantel, Ivermectin, Albendazole

"Standard HIV care plus triple anthelminthic treatment~* Praziquantel 2400mg single dose~* Ivermectin 12 mg, single dose~* Albendazole 400mg, 2 doses in 1 day~All drugs given at baseline, after 6 months and after 12 months."

Trial Locations (1)

P.O. Box 53

Chronic Disease Clinic of St. Francis Designated District Hospital, Ifakara

All Listed Sponsors
collaborator

Ifakara Health Research and Development Centre

OTHER

collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

collaborator

Merck KGaA, Darmstadt, Germany

INDUSTRY

lead

Swiss Tropical & Public Health Institute

OTHER